e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Monitoring asthma: genes, cells and molecules
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2013 abstract - MicroRNA based biomarkers for early risk assessment of asthma
K. Milger, O. Eickelberg, S. Krauss-Etschmann, S. Dehmel (Munich, Germany)
Source:
Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Session:
Monitoring asthma: genes, cells and molecules
Session type:
Thematic Poster Session
Number:
1109
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Milger, O. Eickelberg, S. Krauss-Etschmann, S. Dehmel (Munich, Germany). LSC 2013 abstract - MicroRNA based biomarkers for early risk assessment of asthma. Eur Respir J 2013; 42: Suppl. 57, 1109
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Young Investigator session: MicroRNA based biomarkers for early risk assessment of asthma
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Clinical predictive rules to identify preschool wheezers at risk for subsequent asthma: Can we rely on them? Could we improve their performance?
Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy
Year: 2012
Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Different definitions in childhood asthma: how dependable is the dependent variable?
Source: Eur Respir J 2010; 36: 48-56
Year: 2010
Is it possible to identify phenotypes of problematic severe asthma in children using fluctuation based clustering?
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016
Novel proteomic biomarkers in the evaluation of childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Blood biomarker algorithms to guide COPD assessment and risk stratification
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Systematic review of childhood asthma prediction models
Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia
Year: 2015
Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score
Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016
Year: 2017
Monitoring asthma - state-of-the-art physiological, imaging and biomarker assessments
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018
Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept